先付后捐策略对中国15至18岁女孩减少HPV疫苗延迟并提高接种率的效果:一项随机对照试验
在中国成都四家社区卫生服务中心开展的随机对照试验中,将321名15至18岁未接种HPV疫苗女孩随机分为先付后捐组(161人,获47.7美元社区补贴覆盖首剂疫苗并有支持他人的机会)和对照组(160人,自费按市场价接种)。先付后捐组首剂HPV疫苗接种率为34.2%(55/161),对照组为17.5%(28/160),调整后比例差为17.9%(95%CI [8.7%, 27.0%];P<0.001)。作者认为先付后捐策略有效提高了青少年女孩的补种HPV疫苗接种率。
要点
- 先付后捐组首剂HPV疫苗接种率34.2%(55/161),对照组17.5%(28/160),调整后比例差17.9%(95%CI [8.7%, 27.0%];P<0.001)。
- 先付后捐组55名接种女孩中37人(67.3%)写了明信片留言,39人(70.9%)的照护者捐款支持未来女孩。
- 每人接种财务成本对照组为294美元,先付后捐组为230美元。
核心结论
- 作者认为先付后捐策略有效提高了青少年女孩的补种HPV疫苗接种率,并增强了参与者的疫苗信心。
- 作者认为先付后捐通过社区参与展现出作为提高疫苗接种率有效干预措施的潜力。
研究设计与样本
- 随机对照试验,于2022年7月6日至2023年6月9日在中国成都四家社区卫生服务中心开展。
- 通过电话邀请识别662名参与者,321名参与者到场并随机分配至先付后捐组(n=161)或对照组(n=160)。
- 先付后捐组获得47.7美元社区补贴覆盖首剂疫苗并有支持他人的机会,对照组自费按市场价接种。
- 采用密封信封法随机分组,主要结局为首剂HPV疫苗接种率,依据临床记录核实,采用意向性分析。
主要发现
- 先付后捐组55/161(34.2%)女孩接种HPV疫苗,对照组28/160(17.5%)女孩接种,调整后比例差=17.9%(95%CI [8.7%, 27.0%];P<0.001)。
- 先付后捐组55名接种女孩中37人(67.3%)写了明信片留言,39人(70.9%)的照护者捐款支持未来女孩。
- 每人接种财务成本对照组为294美元,先付后捐组为230美元。
- 大多数照护者为女性(80.1%,257/321)。
临床怎么用
- 原文结论未据此给出临床推荐。
局限性
- 试验存在局限性,包括54%的到诊率(662名同意参与者中360人到场)。
- 试验在中国西部单一省份开展。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Catch-up human papillomavirus (HPV) vaccination is challenging in many low- and middle-income countries (LMICs). Pay-it-forward offers an individual a subsidized vaccine, then an opportunity to donate to help others access vaccinations. Our randomized control trial assessed the effectiveness of pay-it-forward in improving HPV vaccination among girls aged 15-18 years in China. METHODS AND FINDINGS: This study was conducted from July 6, 2022, to June 9, 2023, in four community health centers (CHCs) in Chengdu, western China. Eligible participants were unvaccinated girls living in the service areas of CHCs. Participants were initially recruited via telephone and, after providing verbal consent, attended in-person visit where they were randomly assigned using the sealed envelope method to either the pay-it-forward arm (received a community subsidy of 47.7 USD covering the first vaccine and an opportunity to support others) or control arm (self-paid vaccination at the market price). Participants were unblinded only after the envelope was opened, while the CHC staff coordinators, physicians prescribing the vaccine, outcome assessors, and data analysts were blinded to the intervention allocation. The primary outcome was the first-dose HPV vaccination rate, verified against clinical records. Data were analyzed using the intention-to-treat approach. We identified 662 participants per phone invitation. A total of 321 participants showed up in the health centers and randomly assigned to the pay-it-forward arm (n = 161) or control arm (n = 160). Most caregivers were female (80.1%, 257/321). In the pay-it-forward arm, 55 of 161 (34.2%) girls received the HPV vaccine, compared with 28 of 160 (17.5%) girls in the control arm (adjusted proportion difference = 17.9%, (95% CI [8.7%, 27.0%]; P < 0.001). Among 55 girls in the pay-it-forward arm who received the vaccination, 37 (67.3%) wrote a postcard message, and 39 (70.9%) of their caregivers donated to support future girls. The financial cost per person vaccinated was $294 in the control arm and $230 in the pay-it-forward arm. The trial had several limitations, including a 54% clinic attendance rate (360 of 662 consented participants attended) and its conduct in a single western province of China. CONCLUSIONS: The pro-social pay-it-forward strategy was effective to increase catch-up HPV vaccination among teenage girls. This approach also enhanced vaccine confidence among participants. Pay-it-forward demonstrates promise as an effective intervention to improve vaccine uptake through community engagement. TRIAL REGISTRATION: Chinese clinical trial registry ChiCTR2200055542 (https://www.chictr.org.cn/hvshowproject.html?id=183292&v=1.3).
引用
- Li J, Li Y, Qin C, et al. Effect of a pay-it-forward strategy on reducing HPV vaccine delay and increasing uptake among 15- to 18-year-old girls in China: A randomized controlled trial. PLoS Med. 2025. PMID: 40743312. doi:10.1371/journal.pmed.1004535
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。